Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA accepts application for psoriasis drug: Sun Pharma

      USFDA accepts application for psoriasis drug: Sun Pharma

      Ruby Khatun Khatun25 May 2017 1:43 PM IST
      New Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab...
      Orchid Pharma gets USFDA approval for Aripiprazole tablet

      Orchid Pharma gets USFDA approval for Aripiprazole tablet

      Ruby Khatun Khatun25 May 2017 1:38 PM IST
      Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application (ANDA) approval from US FDA for...
      Patient develops brain infection after taking MS Drug: Roche to investgiate

      Patient develops brain infection after taking MS Drug: Roche to investgiate

      Ruby Khatun Khatun25 May 2017 1:37 PM IST
      ZURICH: A person in Germany treated with Roche's new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after...
      Taro Pharmaceuticals recalls over 7.7 thousand tubes of Fluocinonide cream from US

      Taro Pharmaceuticals recalls over 7.7 thousand tubes of Fluocinonide cream from US

      Ruby Khatun Khatun25 May 2017 1:34 PM IST
      New Delhi: Domestic drug major Sun Pharma's arm Taro Pharmaceuticals USA, Inc is recalling over 7.7 thousand tubes of Fluocinonide cream, used for...
      Dr Reddys, Dept of Science and Technology, Hyderabad University to develop anti-psoriatic drugs

      Dr Reddys, Dept of Science and Technology, Hyderabad University to develop anti-psoriatic drugs

      Ruby Khatun Khatun25 May 2017 1:34 PM IST
      Hyderabad: The Department of Science and Technology (DST), Dr Reddys Laboratories (DRL) and University of Hyderabad (UoH) have joined hands to...
      Pharma stocks slip; Lupin top loser after posting Q4 earnings

      Pharma stocks slip; Lupin top loser after posting Q4 earnings

      Ruby Khatun Khatun25 May 2017 1:33 PM IST
      The pharma stocks have been trading with weakness on the Wednesday’s trading session. Lupin is the top loser in the Nifty pharma index trading lower...
      Granules India to Add 102 Jobs, Invest 35 Million dollar in Virginia

      Granules India to Add 102 Jobs, Invest 35 Million dollar in Virginia

      Ruby Khatun Khatun24 May 2017 12:28 PM IST
      Fairfax County: Governor Terry McAuliffe announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million...
      Prev

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok